EVOK
Price
$4.46
Change
-$0.06 (-1.33%)
Updated
Oct 17 closing price
Capitalization
6.95M
RMTI
Price
$1.17
Change
-$0.02 (-1.68%)
Updated
Oct 17 closing price
Capitalization
40.28M
25 days until earnings call
Interact to see
Advertisement

EVOK vs RMTI

Header iconEVOK vs RMTI Comparison
Open Charts EVOK vs RMTIBanner chart's image
Evoke Pharma
Price$4.46
Change-$0.06 (-1.33%)
Volume$46.08K
Capitalization6.95M
Rockwell Medical
Price$1.17
Change-$0.02 (-1.68%)
Volume$347.25K
Capitalization40.28M
EVOK vs RMTI Comparison Chart in %
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVOK vs. RMTI commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVOK is a Hold and RMTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (EVOK: $4.46 vs. RMTI: $1.17)
Brand notoriety: EVOK and RMTI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: EVOK: 23% vs. RMTI: 19%
Market capitalization -- EVOK: $6.95M vs. RMTI: $40.28M
EVOK [@Pharmaceuticals: Generic] is valued at $6.95M. RMTI’s [@Pharmaceuticals: Generic] market capitalization is $40.28M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVOK’s FA Score shows that 0 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).

  • EVOK’s FA Score: 0 green, 5 red.
  • RMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, EVOK is a better buy in the long-term than RMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVOK’s TA Score shows that 3 TA indicator(s) are bullish while RMTI’s TA Score has 4 bullish TA indicator(s).

  • EVOK’s TA Score: 3 bullish, 5 bearish.
  • RMTI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both EVOK and RMTI are a bad buy in the short-term.

Price Growth

EVOK (@Pharmaceuticals: Generic) experienced а -2.83% price change this week, while RMTI (@Pharmaceuticals: Generic) price change was +6.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Reported Earning Dates

RMTI is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMTI($40.3M) has a higher market cap than EVOK($6.95M). EVOK YTD gains are higher at: 0.905 vs. RMTI (-42.647). RMTI has higher annual earnings (EBITDA): 1.23M vs. EVOK (-4.88M). RMTI has more cash in the bank: 18.4M vs. EVOK (12.1M). EVOK has less debt than RMTI: EVOK (5.13M) vs RMTI (14M). RMTI has higher revenues than EVOK: RMTI (88M) vs EVOK (12.8M).
EVOKRMTIEVOK / RMTI
Capitalization6.95M40.3M17%
EBITDA-4.88M1.23M-396%
Gain YTD0.905-42.647-2%
P/E Ratio0.04N/A-
Revenue12.8M88M15%
Total Cash12.1M18.4M66%
Total Debt5.13M14M37%
FUNDAMENTALS RATINGS
EVOK vs RMTI: Fundamental Ratings
EVOK
RMTI
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
4665
P/E GROWTH RATING
1..100
77100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMTI's Valuation (45) in the Medical Specialties industry is in the same range as EVOK (46) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew similarly to EVOK’s over the last 12 months.

RMTI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as EVOK (100) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew similarly to EVOK’s over the last 12 months.

RMTI's SMR Rating (95) in the Medical Specialties industry is in the same range as EVOK (99) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew similarly to EVOK’s over the last 12 months.

EVOK's Price Growth Rating (46) in the Pharmaceuticals Other industry is in the same range as RMTI (65) in the Medical Specialties industry. This means that EVOK’s stock grew similarly to RMTI’s over the last 12 months.

EVOK's P/E Growth Rating (77) in the Pharmaceuticals Other industry is in the same range as RMTI (100) in the Medical Specialties industry. This means that EVOK’s stock grew similarly to RMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVOKRMTI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNT42.511.11
+2.68%
Vontier Corp
ISRG446.1311.51
+2.65%
Intuitive Surgical
LOCO9.400.18
+1.95%
El Pollo Loco Holdings
AMPL9.690.09
+0.94%
Amplitude
BAFN9.51-0.05
-0.52%
BayFirst Financial Corp

RMTI and

Correlation & Price change

A.I.dvisor tells us that RMTI and AVDL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RMTI and AVDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMTI
1D Price
Change %
RMTI100%
-1.68%
AVDL - RMTI
32%
Poorly correlated
+1.47%
EVOK - RMTI
30%
Poorly correlated
-1.33%
SNDL - RMTI
29%
Poorly correlated
-2.10%
EBS - RMTI
28%
Poorly correlated
-2.55%
HROW - RMTI
28%
Poorly correlated
+5.51%
More